Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for LISDEXAMFETAMINE DIMESYLATE

Ingredient

LISDEXAMFETAMINE DIMESYLATE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ LISDEXAMFETAMINE CAPSULES	60MG	CAPSULE	Resolved	2024-09-23	2025-01-13	238335
SANDOZ LISDEXAMFETAMINE CAPSULES	10MG	CAPSULE	Resolved	2024-10-15	2024-10-22	240305
SANDOZ LISDEXAMFETAMINE CAPSULES	30MG	CAPSULE	Resolved	2024-12-23	2025-01-13	246345
SANDOZ LISDEXAMFETAMINE CAPSULES	40MG	CAPSULE	Resolved	2024-09-23	2025-01-13	238331
SANDOZ LISDEXAMFETAMINE CAPSULES	50MG	CAPSULE	Resolved	2024-09-16	2025-01-13	237754
SANDOZ LISDEXAMFETAMINE CAPSULES	40MG	CAPSULE	Resolved	2025-03-03	2025-04-29	251578
TARO-LISDEXAMFETAMINE CHEWABLE TABLETS	40MG	TABLET (CHEWABLE)	Resolved	2025-07-25	2025-09-29	263597
VYVANSE	10MG	TABLET (CHEWABLE)	Resolved	2021-12-02	2021-12-12	150423
VYVANSE	70MG	CAPSULE	Resolved	2018-06-04	2018-06-13	51253
VYVANSE	10MG	CAPSULE	Resolved	2024-02-27	2024-03-18	220802

1
2
3
Next

Showing 1 to 10 of 22

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0